Cervical Cancer

Patient interest in self-collected HPV screening, one-dose HPV vaccine effectiveness, adolescents’ lower rates of person-centered contraceptive counseling, LNG-IUD dose and acne risk, FDA approval of new oral gonorrhea therapies

Managing implant-related bleeding, Misoprostol route options for cervical priming, access gaps to 12-month contraceptive supplies, clinician beliefs about reporting self-managed abortion

Partner treatment for recurrent BV, ACOG contraceptive access update, de-implementing early pregnancy RhIG, tampon use with contraceptive vaginal rings, WHO MEC and SPR updates

DMPA on TikTok, OTC pill sales, Misoprostol & IUD placements, Telehealth abortion & TGD populations, Abortion restrictions & infant mortality

Contraceptive knowledge gaps, Adolescent awareness of OTC contraception, DMPA and meningioma risk, Implicit bias in contraception counseling, PrEP & STI Risk

HPV self-collection is here. FDA-approved in 2024, self-swabbing lets many patients collect their own sample in the clinic, offering a safe, evidence-based option to expand cervical cancer screening access and support patient-centered care.

HPV self-collection, asynchronous telehealth abortion studies, young people and permanent contraception access, clinician confidence gaps in abortion navigation, shifting contraceptive preferences postpartum

What providers need to know about putting the 2019 ASCCP Risk-Based Management Consensus Guidelines into practice